EUVIMEDOdkrijte EUVIMED
Übersichtsarbeit

Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic Applications

Hongmei Liu, Yixuan Song, Huan Wang, Ying Zhou, Min Xu, Jiaxun Xian iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8433 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2025. Written by Hongmei Liu and 5 co-authors. Institution: Department of Pharmacy, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China. Major MEDLINE topics: Mitophagy, Resveratrol, Stilbenes. Cited 36 times so far (Crossref); 183 references. Funded by: National Natural Science Foundation of China.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Resveratrol (RES), a natural polyphenolic compound, has garnered significant attention for its therapeutic potential in various pathological conditions. This review explores how RES modulates mitophagy—the selective autophagic degradation of mitochondria essential for maintaining cellular homeostasis. RES promotes the initiation and execution of mitophagy by enhancing PINK1/Parkin‐mediated mitochondrial clearance, reducing reactive oxygen species production, and mitigating apoptosis, thereby preserving mitochondrial integrity. Additionally, RES regulates mitophagy through the activation of key molecular targets such as AMP‐activated protein kinase (AMPK), the mechanistic target of rapamycin (mTOR), deacetylases (SIRT1 and SIRT3), and mitochondrial quality control (MQC) pathways, demonstrating substantial therapeutic effects in multiple disease models. We provide a detailed account of the biosynthetic pathways, pharmacokinetics, and metabolic characteristics of RES, focusing on its role in mitophagy modulation and implications for medical applications. Potential adverse effects associated with its clinical use are also discussed. Despite its promising therapeutic properties, the clinical application of RES is limited by issues of bioavailability and pharmacokinetic profiles. Future research should concentrate on enhancing RES bioavailability and developing derivatives that precisely modulate mitophagy, thereby unlocking new avenues for disease therapy.

Subjects

MeSH terms (MEDLINE)

MitophagyResveratrolStilbenesHumansAnimalsMitochondriaReactive Oxygen SpeciesProtein KinasesTOR Serine-Threonine KinasesAMP-Activated Protein KinasesUbiquitin-Protein LigasesPTEN-Induced Putative Kinase

Author keywords

AMPKPINK1/ParkinSIRT1disease interventionmitophagyresveratrol

Substances

ResveratrolStilbenesReactive Oxygen SpeciesProtein KinasesTOR Serine-Threonine KinasesAMP-Activated Protein KinasesUbiquitin-Protein LigasesPTEN-Induced Putative Kinaseparkin protein

Authors and institutions

  • Department of Pharmacy, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Traditional Chinese Medicine Hospital of Meishan, Meishan, China.

ORCID profiles: Jiaxun Xian

Funding

  • National Natural Science Foundation of China

Cite

APA

Liu, H., Song, Y., Wang, H., Zhou, Y., Xu, M., & Xian, J. (2025). Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic Applications. Phytotherapy Research. https://doi.org/10.1002/ptr.8433

Vancouver

Liu H, Song Y, Wang H, Zhou Y, Xu M, Xian J. Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic Applications. Phytotherapy Research. 2025. doi:10.1002/ptr.8433

BibTeX
@article{Liu2025,
  author = {Liu, Hongmei and Song, Yixuan and Wang, Huan and Zhou, Ying and Xu, Min and Xian, Jiaxun},
  title = {Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic Applications},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8433}
}
Start for free →